Literature DB >> 26746211

Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor.

Edyta Gendaszewska-Darmach1, Marcin Szustak2.   

Abstract

ATP, ADP, UTP, and UDP acting as ligands of specific P2Y receptors activate intracellular signaling cascades to regulate a variety of cellular processes, including proliferation, migration, differentiation, and cell death. Contrary to a widely held opinion, we show here that nucleoside 5'-O-monophosphorothioate analogs, containing a sulfur atom in a place of one nonbridging oxygen atom in a phosphate group, act as ligands for selected P2Y subtypes. We pay particular attention to the unique activity of thymidine 5'-O-monophosphorothioate (TMPS) which acts as a specific partial agonist of the P2Y6 receptor (P2Y6R). We also collected evidence for the involvement of the P2Y6 receptor in human epithelial adenocarcinoma cell line (HeLa) cell migration induced by thymidine 5'-O-monophosphorothioate analog. The stimulatory effect of TMPS was abolished by siRNA-mediated P2Y6 knockdown and diisothiocyanate derivative MRS 2578, a selective antagonist of the P2Y6R. Our results indicate for the first time that increased stability of thymidine 5'-O-monophosphorothioate as well as its affinity toward the P2Y6R may be responsible for some long-term effects mediated by this receptor.

Entities:  

Keywords:  Cell migration; HeLa cells; Nucleoside 5′-O-monophosphorothioates; P2Y receptors; P2Y6

Mesh:

Substances:

Year:  2016        PMID: 26746211      PMCID: PMC4854834          DOI: 10.1007/s11302-015-9492-1

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  52 in total

1.  Degradation of extracellular nucleotides and their analogs in HeLa and HUVEC cell cultures.

Authors:  Edyta Gendaszewska-Darmach; Maria Maszewska; Małgorzata Zakłos; Maria Koziołkiewicz
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

2.  Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.

Authors:  Hiroshi Maruoka; Matthew O Barrett; Hyojin Ko; Dilip K Tosh; Artem Melman; Lauren E Burianek; Ramachandran Balasubramanian; Barkin Berk; Stefano Costanzi; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

3.  Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors.

Authors:  N Huang; D J Wang; L A Heppel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.

Authors:  Jasminka Korcok; Lin N Raimundo; Xiaobing Du; Stephen M Sims; S Jeffrey Dixon
Journal:  J Biol Chem       Date:  2005-02-18       Impact factor: 5.157

5.  Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.

Authors:  Stefano Costanzi; Bhalchandra V Joshi; Savitri Maddileti; Liaman Mamedova; Maria J Gonzalez-Moa; Victor E Marquez; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

6.  Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation.

Authors:  Liaman K Mamedova; Ruibo Wang; Pedro Besada; Bruce T Liang; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2008-08-30       Impact factor: 7.658

Review 7.  Extracellular ATP: a growth factor for vascular smooth muscle cells.

Authors:  D Erlinge
Journal:  Gen Pharmacol       Date:  1998-07

8.  P2Y(6) agonist uridine 5'-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes/macrophages recruitment.

Authors:  Zhi Zhang; Ziqiang Wang; Hua Ren; Miaomiao Yue; Kan Huang; Hongjie Gu; Mingyao Liu; Bing Du; Min Qian
Journal:  J Immunol       Date:  2011-03-28       Impact factor: 5.422

9.  Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells.

Authors:  C M Satterwhite; A M Farrelly; M E Bradley
Journal:  Am J Physiol       Date:  1999-03

10.  Proangiogenic properties of nucleoside 5'-O-phosphorothioate analogues under hyperglycaemic conditions.

Authors:  Edyta Węgłowska; Marcin Szustak; Edyta Gendaszewska-Darmach
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

View more
  9 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 2.  Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets.

Authors:  Maria Luiza Mukai Franciosi; Thiago Inácio Teixeira do Carmo; Daniela Zanini; Andréia Machado Cardoso
Journal:  Inflamm Res       Date:  2022-04-04       Impact factor: 4.575

Review 3.  Purinergic signaling and tumor microenvironment in cervical Cancer.

Authors:  Marta Schmidt Pfaffenzeller; Maria Luiza Mukai Franciosi; Andréia Machado Cardoso
Journal:  Purinergic Signal       Date:  2020-03-13       Impact factor: 3.765

Review 4.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

5.  Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.

Authors:  Edyta Gendaszewska-Darmach; Edyta Węgłowska; Aurelia Walczak-Drzewiecka; Kaja Karaś
Journal:  Oncotarget       Date:  2016-10-25

6.  Extracellular Nucleotides Selectively Induce Migration of Chondrocytes and Expression of Type II Collagen.

Authors:  Marcin Szustak; Edyta Gendaszewska-Darmach
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

7.  A purinergic P2Y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma.

Authors:  Anne Chetty; Azeem Sharda; Rod Warburton; Ellen O Weinberg; Jinghui Dong; Min Fang; G Gary Sahagian; Tiangmeng Chen; Chang Xue; John J Castellot; Philip G Haydon; Heber C Nielsen
Journal:  J Asthma Allergy       Date:  2018-08-01

8.  Extracellular Nucleotides Affect the Proangiogenic Behavior of Fibroblasts, Keratinocytes, and Endothelial Cells.

Authors:  Edyta Węgłowska; Maria Koziołkiewicz; Daria Kamińska; Bartłomiej Grobelski; Dariusz Pawełczak; Marek Kołodziejczyk; Stanisław Bielecki; Edyta Gendaszewska-Darmach
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

9.  Intracellular HINT1-Assisted Hydrolysis of Nucleoside 5'-O-Selenophosphate Leads to the Release of Hydrogen Selenide That Exhibits Toxic Effects in Human Cervical Cancer Cells.

Authors:  Agnieszka Krakowiak; Liliana Czernek; Marta Pichlak; Renata Kaczmarek
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.